Global Drugs for Infertility Markets to 2022 Featuring Bayer, Merck, Sanofi, Ferring Holding, Abbott Laboratories

Global Drugs for Infertility Markets to 2022 Featuring Bayer, Merck, Sanofi, Ferring Holding, Abbott Laboratories

DUBLIN, March 29, 2018 /PRNewswire/ --

The "Drugs for Infertility: Global Markets to 2022" report has been added to ResearchAndMarkets.com's

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The global drugs for infertility market is registering growth due to growing infertile population and rising awareness about infertility treatments in both developed and developing countries.

At the same time, economic growth in emerging countries, increasing prevalence of obesity and new methods of drug development are also driving the drugs for infertility market.The market for drugs for infertility is concentrated with a few large players dominating the market.

Major players in the market are Bayer, Merck, Sanofi, Ferring Holding, Abbott Laboratories and others. Gonadotropins accounted for the largest share of the market for drugs for infertility in 2017. The highest growth is projected to come from Gonadotropins.

Major factors included increasing demand for fertility treatments, especially in Asia-Pacific andSouth America, changing government regulations related to operation of chorionic gonadotropin and increasing investments on product differentiations.

North America is the largest market for drugs for infertility. It was followed by Asia-Pacific and Africa. Going forward, Eastern Europe is expected to witness the fastest growth in the drugs for infertility market, followed by South America. The USA is the largest market in terms of value in the drugs for infertility market.

The market is challenged by restraints such as patent expiry of fertility drugs, high costs of fertility treatments and pricing pressures from regulators

Report Includes:

    --  95 data tables
    --  An overview of the global market for infertility drugs and their future
        demand
    --  Analyses of global market trends, with data from 2013 to 2017, and
        projections of compound annual growth rates (CAGRs) through 2022
    --  Discussion of the various causes of infertility among men and women and
        pharmaceutical drugs that enhance the reproductive fertility
    --  Insight into the type of infertility drugs, i.e., anti-estrogens and
        gonadotropins

    --  Profiles of major companies in the market, including Bayer, Merck,
        Sanofi, Ferring Holding and Abbott Laboratories

Key Topics Covered:

1 Introduction

2 Summary and Highlights

3 Drugs for Infertility Market Characteristics

4 Drugs for Infertility Market Size and Growth

    --  Historic Market Growth
    --  Drivers of the Market
    --  Restraints on the Market
    --  Forecast Market Growth
    --  Drivers of the Market
    --  Restraints on the Market

5 Drugs for Infertility Market Trends and Strategies

    --  Turning Away from Animal Testing
    --  Recombinant Follicle Stimulating Hormone (FSH) To Treat Female
        Infertility
    --  New Drugs to Treat Male Infertility

6 PESTLE Analysis

    --  Political
    --  Economic
    --  Social
    --  Technological
    --  Legal
    --  Environmental

7 Drugs for Infertility Market Segmentation

    --  Global Drugs for Infertility Market, by Segment
    --  Global Drugs for Infertility Market, Historic and Forecast, by Segment,
        2013-2022
    --  Anti-Estrogens Market
    --  Market Characteristics
    --  Market Trends and Strategies
    --  Gonadotropins Market
    --  Market Characteristics
    --  Trends and Strategies

8 Drugs for Infertility Market Regional and Country Analysis

    --  Global Drugs for Infertility Market, by Region
    --  Global Drugs for Infertility Market, 2013-2022, Historic and Forecast,
        by Region
    --  Global Drugs for Infertility Market Segmentation, by Region, 2017
    --  Global Drugs for Infertility Market, by Country
    --  Global Drugs for Infertility Market, Historic and Forecast, by Country
    --  Global Drugs for Infertility Market Segmentation, 2017, by Country

9 Global Drugs for Infertility Market Comparison with Macro Economic Factors

    --  Global Per Capita Average Drugs for Infertility Market Expenditure
    --  Per Capita Average Drugs for Infertility Market Expenditure, by Country

10 Asia-Pacific Drugs for Infertility Market

    --  Asia-Pacific Drugs for Infertility Market Overview
    --  Region Information
    --  Background Information
    --  Regulations
    --  Regulatory Bodies
    --  Associations
    --  Government Initiatives
    --  Competitive Landscape
    --  Asia-Pacific Drugs for Infertility Historic Market, 2013-2017
    --  Asia-Pacific Drugs for Infertility Forecast Market, 2017-2022
    --  Asia-Pacific Drugs for Infertility Market, by Segment
    --  Asia-Pacific Drugs for Infertility Market, Historic and Forecast CAGR,
        by Segment

11 Asia-Pacific Drugs for Infertility Market: Country Analysis

    --  China Drugs for Infertility Market Overview
    --  Country Information
    --  Background Information
    --  Regulations
    --  Regulatory Bodies
    --  Associations
    --  Government Initiatives
    --  Investments
    --  Competitive Landscape
    --  China Drugs for Infertility Historic Market, 2013-2017
    --  China Drugs for Infertility Forecast Market, 2017-2022
    --  China Drugs for Infertility Market, by Segment
    --  China Drugs for Infertility Market, 2013-2022, Historic and Forecast, by
        Segment
    --  India Drugs for Infertility Market Overview
    --  Country Information
    --  Background Information
    --  Regulations
    --  Regulatory Bodies
    --  Associations
    --  Government Initiatives
    --  Investments
    --  Competitive Landscape
    --  India Drugs for Infertility Historic Market, 2013-2017
    --  India Drugs for Infertility Forecast Market, 2017-2022
    --  India Drugs for Infertility Market, by Segment
    --  India Drugs for Infertility Market, 2013-2022, Historic and Forecast, by
        Segment
    --  Japan Drugs for Infertility Market Overview
    --  Country Information
    --  Background Information
    --  Regulations
    --  Regulatory Bodies
    --  Associations
    --  Government Initiatives
    --  Investments
    --  Competitive Landscape
    --  Japan Drugs for Infertility Historic Market, 2013-2017
    --  Japan Drugs for Infertility Forecast Market, 2017-2022
    --  Japan Drugs for Infertility Market, by Segment
    --  Japan Drugs for Infertility Market, 2013-2022, Historic and Forecast, by
        Segment
    --  Australia Drugs for Infertility Market
    --  Australia Drugs for Infertility Historic Market, 2013-2017
    --  Australia Drugs for Infertility Forecast Market, 2017-2022
    --  Australia Drugs for Infertility Market, by Segment
    --  Australia Drugs for Infertility Market, 2013-2022, Historic and
        Forecast, by Segment

12 Western Europe Drugs for Infertility Market

    --  Western Europe Drugs for Infertility Market Overview
    --  Region Information
    --  Background Information
    --  Regulations
    --  Regulatory Bodies
    --  Associations
    --  Government Initiatives
    --  Investments
    --  Competitive Landscape
    --  Western Europe Drugs for Infertility Historic Market, 2013-2017
    --  Western Europe Drugs for Infertility Forecast Market, 2017-2022
    --  Western Europe Drugs for Infertility Market, by Segment
    --  Western Europe Drugs for Infertility Market, 2013-2022, Historic and
        Forecast, by Segment

13 Western Europe Drugs for Infertility Market: Country Analysis

    --  UK Drugs for Infertility Market Overview
    --  Country Information
    --  Background Information
    --  Regulations
    --  Taxes Levied
    --  Regulatory Bodies
    --  Associations
    --  Government Initiatives
    --  Investments
    --  Competitive Landscape
    --  UK Drugs for Infertility Historic Market, 2013-2017
    --  UK Drugs for Infertility Forecast Market, 2017-2022
    --  UK Drugs for Infertility Market, by Segment
    --  UK Drugs for Infertility Market, 2013-2022, Historic and Forecast, by
        Segment
    --  Germany Drugs for Infertility Market
    --  Germany Drugs for Infertility Historic Market, 2013-2017
    --  Germany Drugs for Infertility Forecast Market, 2017-2022
    --  Germany Drugs for Infertility Market, by Segment
    --  Germany Drugs for Infertility Market, 2013-2022, Historic and Forecast,
        by Segment
    --  France Drugs for Infertility Market
    --  France Drugs for Infertility Historic Market, 2013-2017
    --  France Drugs for Infertility Forecast Market, 2017-2022
    --  France Drugs for Infertility Market, by Segment
    --  France Drugs for Infertility Market, Historic and Forecast, by Segment,
        2013-2022
    --  Italy Drugs for Infertility Market
    --  Italy Drugs for Infertility Historic Market, 2013-2017
    --  Italy Drugs for Infertility Forecast Market, 2017-2022
    --  Italy Drugs for Infertility Market, by Segment
    --  Italy Drugs for Infertility Market, Historic and Forecast, by Segment,
        2013-2022
    --  Spain Drugs for Infertility Market
    --  Spain Drugs for Infertility Historic Market, 2013-2017
    --  Spain Drugs for Infertility Forecast Market, 2017-2022
    --  Spain Drugs for Infertility Market, by Segment
    --  Spain Drugs for Infertility Market, Historic and Forecast, by Segment,
        2013-2022

14 Eastern Europe Drugs for Infertility Market

    --  Eastern Europe Drugs for Infertility Market Overview
    --  Region Information
    --  Background Information
    --  Regulations
    --  Regulatory Bodies
    --  Associations
    --  Government Initiatives
    --  Investments
    --  Competitive Landscape
    --  Eastern Europe Drugs for Infertility Historic Market, 2013-2017
    --  Eastern Europe Drugs for Infertility Forecast Market, 2017-2022
    --  Eastern Europe Drugs for Infertility Market, by Segment
    --  Eastern Europe Drugs for Infertility Market, Historic and Forecast, by
        Segment, 2013-2022

15 Eastern Europe Drugs for Infertility Market: Country Analysis

    --  Russia Drugs for Infertility Market
    --  Russia Drugs for Infertility Historic Market, 2013-2017
    --  Russia Drugs for Infertility Forecast Market, 2017-2022
    --  Russia Drugs for Infertility Market, by Segment
    --  Russia Drugs for Infertility Market, Historic and Forecast, by Segment,
        2013-2022

16 North America Drugs for Infertility Market

    --  North America Drugs for Infertility Market Overview
    --  Region Information
    --  Background Information
    --  Regulations
    --  Taxes Levied
    --  Regulatory Bodies
    --  Associations
    --  Government Initiatives
    --  Investments
    --  Competitive Landscape
    --  North America Drugs for Infertility Historic Market, 2013-2017
    --  North America Drugs for Infertility Forecast Market, 2017-2022
    --  North America Drugs for Infertility Market, by Segment
    --  North America Drugs for Infertility Market, Historic and Forecast, by
        Segment, 2013-2022

17 North America Drugs for Infertility Market: Country Analysis

    --  USA Drugs for Infertility Market
    --  USA Drugs for Infertility Historic Market, 2013-2017
    --  USA Drugs for Infertility Forecast Market, 2017-2022
    --  USA Drugs for Infertility Market, by Segment
    --  USA Drugs for Infertility Market, 2013-2022, Historic and Forecast, by
        Segment

18 South America Drugs for Infertility Market

    --  South America Drugs for Infertility Market Overview
    --  Region Information
    --  Background Information
    --  Regulations
    --  Regulatory Bodies
    --  Associations
    --  Government Initiatives
    --  Competitive Landscape
    --  South America Drugs for Infertility Historic Market, 2013-2017
    --  South America Drugs for Infertility Forecast Market, 2017-2022
    --  South America Drugs for Infertility Market, by Segment
    --  South America Drugs for Infertility Historic and Forecast Market, by
        Segment, 2013-2022

19 South America Drugs for Infertility Market: Country Analysis

    --  Brazil Drugs for Infertility Market
    --  Brazil Drugs for Infertility Historic Market, 2013-2017
    --  Brazil Drugs for Infertility Forecast Market, 2017-2022
    --  Brazil Drugs for Infertility Market, by Segment
    --  Brazil Drugs for Infertility Historic and Forecast Market, by Segment,
        2013-2022

20 Middle East Drugs for Infertility Market

    --  Middle East Drugs for Infertility Market Overview
    --  Region Information
    --  Background Information
    --  Regulations
    --  Regulatory Bodies
    --  Associations
    --  Government Initiatives
    --  Investments
    --  Competitive Landscape
    --  Middle East Drugs for Infertility Historic Market, 2013-2017
    --  Middle East Drugs for Infertility Forecast Market, 2017-2022
    --  Middle East Drugs for Infertility Market, by Segment
    --  Middle East Drugs for Infertility Historic and Forecast Market, by
        Segment, 2013-2022

21 Africa Drugs for Infertility Market

    --  Africa Drugs for Infertility Market Overview
    --  Region Information
    --  Background Information
    --  Regulations
    --  Regulatory Bodies
    --  Associations
    --  Competitive Landscape
    --  Africa Drugs for Infertility Historic Market, 2013-2017
    --  Africa Drugs for Infertility Forecast Market, 2017-2022
    --  Africa Drugs for Infertility Market, by Segment
    --  Africa Drugs for Infertility Historic and Forecast Market, by Segment,
        2013-2022

22 Drugs for Infertility Market Customer Information

    --  Infertility on the Rise in the US
    --  Survey to Investigate Incidence, Etiology, Treatment Indications, And
        Outcomes in Infertile Males
    --  Fertility Services with Attractive Benefit
    --  Survey of Women and Men Reveals Scale of Infertility

23 Drugs for Infertility Market Competitive Landscape

    --  Company Profiles
    --  Abbott Laboratories
    --  Bayer
    --  Ferring Holding SA
    --  Merck & Co.
    --  Sanofi

24 Key Mergers and Acquisitions in Drugs for Infertility Market

    --  Gedeon Richter Acquired Finox Holding
    --  CVC Acquired International Women's Health Assets of Teva Pharmaceutical
    --  Searchlight Pharma Acquired Besins Healthcare Canada

25 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/6srj55/global_drugs_for?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-drugs-for-infertility-markets-to-2022-featuring-bayer-merck-sanofi-ferring-holding-abbott-laboratories-300621707.html

SOURCE Research and Markets